HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H
Authors:
- Reinhard HobiRHReinhard Hobi
- Kersten LüthiKLKersten Lüthi
- Federico FocherFFFederico Focher
- Ulrich HübscherUHUlrich Hübscher
Open Access
- 11 August 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 19 (15) , 4059-4065
Abstract
Penicillins, cephalosporins and other betalactam antibiotics are widely used antibacterial drugs. Recently it was found that some of them also have effects on proliferating eukaryotic cells (Neftel,K.A. and Hübscher,U. (1987) Antimicrob. Agents Chemother. 31, 1657 – 1661), and one such effect was shown to be the inhibition of DNA polymerase α (Huynh Do,U., Neftel,K.A., Spadari,S. and Hübscher,U. (1987) Nucl. Acids Res. 15, 10495 – 10506). The data suggested that degradation products of betalactam antibiotics were responsible for the inhibitory effect on DNA polymerase α. There is some confirmation at the structural level, since we found that penicillin binding proteins, the natural target of the cephalosporins, share amino-acid homologies to DNA polymerases and also to reverse transcriptase from HIV1 (Hafkemeyer,P., Neftel,K.A. and Hübscher,U. Meth. Find. Exp. Clin. Pharmacol. 12, 43–46, 1990).We have purified and determined the structure of one product from the cephalosporin Ceftazidim and found one molecule (HP 0.35) that did not interfere with eukaryotic cell proliferation but rather had a specific inhibitory effect on the RNase H activity of human immunodeficiency virus 1 (HIV1) and feline immunodeficiency virus (FIV) reverse transcriptases, while the DNA polymerising activity of these enzymes was not affected. RNases H from HeLa cells, calf thymus and Escherichia coli on the other hand were much less affected by HP 0.35. The inhibitory concentration of 50% (IC50) was more than 10 times lower compared to those of all cellular RNases H. We therefore tested the effect of HP 0.35 on in vitro lentivirus infection as exemplified by FIV-Infection of CD4+ -cat lymphocytes in cell culture. Under conditions where cell proliferation was absolutely unaffected, HP 0.35 was able to inhibit FIV-infection in CD4+ -cat lymphocytes. Moreover, preincubation of these lymphocytes with HP 0.35 rendered the cells completely unsusceptible to FIV-infection. These data suggest that a degradation product of a clinically used betalactam antibiotic might represent an effective inhibitor class for lentiviral RNase H.Keywords
This publication has 29 references indexed in Scilit:
- DNA helicase from calf thymus. Purification to apparent homogeneity and biochemical characterization of the enzyme.Journal of Biological Chemistry, 1990
- Revised nomenclature for eukaryotic DNA polymerasesEuropean Journal of Biochemistry, 1990
- Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.Proceedings of the National Academy of Sciences, 1989
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Molecular cloning of feline immunodeficiency virus.Proceedings of the National Academy of Sciences, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Specificity Assessment of Feline T‐Lymphotropic Lentivirus SerologyJournal of Veterinary Medicine, Series B, 1988
- Effects of beta-lactam antibiotics on proliferating eucaryotic cellsAntimicrobial Agents and Chemotherapy, 1987
- Isolation of a T-Lymphotropic Virus from Domestic Cats with an Immunodeficiency-Like SyndromeScience, 1987
- Inhibition of Granulopoiesis in Vivo and in Vitro by -Lactam AntibioticsThe Journal of Infectious Diseases, 1985